Innovating Works

GRU

Desconocido
HemAcure: Application of combined gene and cell therapy within an implantable therapeutic device for the treat... GRUNEWALD VERWALTUNGS GMBH participó en un H2020: H2020-PHC-2014-2015 The main objective of the HemAcure project is to develop and refine the tools and technologies for a novel ex vivo prepared cell based thera...
2015-12-09 - 2018-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.